
Anders H. Kverneland
@ahkverneland
Translational cancer scientist and MD working on #Immunotherapy and #Immunotox @CCITdk @UCPH_CPR @UCPH_BRIDGE
ID: 1235268713286430721
04-03-2020 18:20:07
17 Tweet
55 Followers
62 Following

New #JITC article: Adoptive cell therapy with tumor-infiltrating lymphocytes supported by checkpoint inhibition across multiple solid cancer types ow.ly/TjRX50Glz0W Anders H. Kverneland


#ESMOImmuno21: New #immunotherapies explored to improve treatment of solid tumours. From cell-based therapies to soluble #Tcell engagers & T-cell co-stimulation, early findings show novel promising strategies, but more data needed ow.ly/IVLz50H62qY Marco Donia #CARTcell


Big day for CCIT-DK: National Center for Cancer Immune Therapy! Basic discoveries from CCIT-DK: National Center for Cancer Immune Therapy developed into a clinical trial at CCIT-DK: National Center for Cancer Immune Therapy. Anti-PD1 #immunotherapy plus #vaccine against IDO/PD-L1, impressive response rates. Hope for more effective treatments for patients with #Melanoma #melsm #dkforsk

A 8+ years journey bringing the first results. This is great news for patients and for science. Great work of the previous and current members of the TIL teams at CCIT-DK: National Center for Cancer Immune Therapy and The Netherlands Cancer Institute

Check out our latest publication at Proteomics! In this long-awaited study, Anders Anders H. Kverneland et al. unlock plasma proteomics using extracellular vesicles in simple and scalable workflow. Biomarker discovery research will be deeply changed. …iencejournals.onlinelibrary.wiley.com/doi/10.1002/pm…


Treatment with tumor-infiltrating lymphocytes (#TILs) is a safe and effective treatment for advanced #melanoma. A decade of academic efforts by CCIT-DK: National Center for Cancer Immune Therapy and The Netherlands Cancer Institute published on the NEJM Funding Kræftens Bekæmpelse Region Hovedstaden HerlevGentofte Hosp. and Dutch organizations nejm.org/doi/full/10.10…

Cancer immune therapy is great! But it can be even greater with help from proteomics. Read all about it in our recent review paper from @Giufranciosa and co-authors CCIT-DK: National Center for Cancer Immune Therapy, in Seminars in immunopathology with this exclusive full-text access link: rdcu.be/c2Ncu

Is CPI therapy associated with changes in the peripheral immune system of patients with #melanoma? And are there patterns related to clinical response? Anders H. Kverneland and colleagues from CCIT-DK: National Center for Cancer Immune Therapy investigated the matter, free full text on ESMO IOTECH 👉ow.ly/1HRV50PEpwW


